The FDA approved two new oral therapies to treat uncomplicated urogenital gonorrhea. Both treatments demonstrated comparable effectives when compared to standard treatment.
A new randomized trial in newly formed heterosexual couples investigated whether recent human papillomavirus vaccination protects individuals or their partners against transmission.
In a recent multicenter retrospective case series, isotretinoin was effective in treating acne among transgender and gender-diverse individuals undergoing masculinizing hormone therapy, with significantly...
Sexual and gender minority (SGM) populations face significantly higher odds of being diagnosed with multiple mental health conditions compared with their cisgender heterosexual counterparts, according to a...
In a diverse cohort of virologically suppressed women with HIV, long-acting cabotegravir and rilpivirine (CAB+RPV LA) maintained high rates of viral suppression with low virologic failure over a median...
The CDC reported more than 200,000 cases of syphilis in 2022, a 17% increase compared with the previous year. In response, the CDC provided new recommendations for testing syphilis in the laboratory.
Researchers aimed to determine the risk profile of individuals without HIV who were seeking vaccination against mpox and if these patients would benefit from HIV pre-exposure prophylaxis use.
The USPSTF has released a reaffirmation of their recommendations for screening for genital herpes infection in adolescents, adults, and pregnant persons.
Researchers examined the efficacy of post-exposure prophylaxis for the prevention of sexually transmitted infections among certain patient populations living with HIV or on HIV pre-exposure prophylaxis.
...
